EN
HI
Summary
As of 25 Aug, 2026, Novelix Pharmaceuticals stock price is ₹80.9. During the trading session, the stock has moved between an intraday low of ₹78.00 and an intraday high of ₹83.99. Over the last 52 weeks, Novelix Pharmaceuticals has traded between ₹38.00 and ₹92.00.
The stock has recorded a trading volume of 3,173 shares, with a market capitalization of ₹28470000. Its Average Traded Price (ATP) is ₹80.51, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 50 @ ₹80.90.
Novelix Pharmaceuticals has an upper circuit limit of ₹84.39 and a lower circuit limit of ₹76.37. The total value traded stands at ₹2.55 L, and the delivery percentage for the day is 100%.
The stock is currently traded with a market lot size of 1. Novelix Pharmaceuticals also offers a dividend yield of 0%.
Novelix Pharmaceuticals share price chart
Novelix Pharmaceuticals Share Key Metrics
Volume
3173.00
Market Cap
230.32 CR
LTQ@LTP
50@80.90
ATP
80.51
Var Margin
100 %
Circuit Range
76.37-84.39
Delivery %
100 %
Value
2.55 L
ASM/GSM
No
Market Lot
1
Novelix Pharmaceuticals Fundamentals
P/E Ratio
0
P/B Ratio
0
Div. Yield
0
Sector P/E
60.13
Sector P/B
2.18
Sec. Div. Yield
75.6
Novelix Pharmaceuticals Resistance and Support
Pivot 79.25
Resistance
First Resistance
83.39
Second Resistance
86.39
Third Resistance
90.53
Support
First Support
76.25
Second Support
72.11
Third Support
69.11
Novelix Pharmaceuticals Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Tue Aug 25 2026 | 83.99 | 80.9 | 0.66% | 83.99 | 78 |
| Mon Aug 24 2026 | 82.25 | 80.37 | 2.60% | 82.25 | 75.11 |
| Fri Aug 21 2026 | 77.69 | 78.33 | 2.47% | 79.9 | 74.9 |
Novelix Pharmaceuticals Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-13 | Quarterly Results |
| 2026-06-04 | Preferential Issue of shares & Others |
| 2026-05-29 | Audited Results & Preferential issue |
| 2026-02-12 | Quarterly Results |
| 2025-11-13 | Quarterly Results |
| 2025-08-14 | Quarterly Results & A.G.M. |
| 2025-06-24 | Others |
| 2025-05-27 | Audited Results |
| 2025-02-12 | Quarterly Results |
| 2024-11-13 | Quarterly Results & Others |
| 2024-10-21 | To consider issue of Warrants |
| 2024-10-14 | To consider issue of Warrants |
| 2024-09-02 | Others |
| 2024-08-08 | Quarterly Results |
| 2024-03-05 | Preferential issue of shares |
Novelix Pharmaceuticals News
Novelix Pharmaceuticals Ltd - 536565 - Board Meeting Intimation for Prior Intimation Of Board Meeting To Be Held On Saturday, 29Th August, 2026
Novelix Pharma has intimated a Board Meeting on August 29, 2026. The agenda includes considering and approving the Board Report for the financial year ended March 31, 2026, and the appointment of a Whole Time Director.
Aug 25 2026 18:08:15
Novelix Pharmaceuticals Ltd - 536565 - Announcement Under Regulation 30 (LODR) - Lease Deed
Novelix Pharmaceuticals has executed a 5-year land lease deed for establishing facilities for Micro Algae Cultivation and Glass Reactor Systems in Telangana. The transaction involves a promoter group member at arm's length, expanding the company's operational capabilities.
Aug 20 2026 13:21:36
Read More
Novelix Pharmaceuticals Management
| Name | Position |
|---|---|
| Venkateshwarlu Pulluru | Whole Time Director |
| Janardhan Das Kabra | Non Executive Independent Director |
Novelix Pharmaceuticals Similar Stocks
Novelix Pharmaceuticals FAQs
The Buying Price of Novelix Pharmaceuticals share is 80.9 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Novelix Pharmaceuticals stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Novelix Pharmaceuticals, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Novelix Pharmaceuticals shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Novelix Pharmaceuticals shares is 0. Useful to assess the stock's value relative to its book value.
To assess Novelix Pharmaceuticals’s valuation compare Sector P/E, P/B which are 60.13 & 2.18 with sector averages, along with growth rates and financial metrics.
The Market Cap of Novelix Pharmaceuticals is 230.32 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Novelix Pharmaceuticals share price is 92.00 & 38.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Novelix Pharmaceuticals belongs to the Miscellaneous sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
